Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: The potential as a new asthma medication

International Immunopharmacology

Volumn 9, Issue 11, 2009, Pages 1337-1341

  Muraki, Masato ^a   Imbe, Shu ^a   Sato, Ryuji ^a   Ikeda, Yoko ^a   Yamagata, Shigeyoshi ^a   Iwanaga, Takashi ^a   Tohda, Yuji ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Asthma; Bronchoconstriction response; Inhalation; Leukotrienes; Montelukast

Indexed keywords

LEUKOTRIENE C4; LEUKOTRIENE D4; MONTELUKAST; OVALBUMIN;

AIRWAY PRESSURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; EXPERIMENTAL GUINEA PIG; HISTOPATHOLOGY; LUNG PARENCHYMA; MALE; NONHUMAN; OXYGEN TENSION; PRIORITY JOURNAL; SENSITIZATION; TISSUE INJURY;

ACETATES; ADMINISTRATION, INHALATION; ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHOCONSTRICTION; CYSTEINE; DISEASE MODELS, ANIMAL; GUINEA PIGS; IMMUNOLOGIC FACTORS; LEUKOTRIENE ANTAGONISTS; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENES; LUNG; MALE; OVALBUMIN; QUINOLINES;

EID: 70249108874     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2009.08.007     Document Type: Article

References (28)

1. The Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention 2006. 2006 Medical Communications Resources, Inc., 2006.
2. Skoner J.D., Schaffner T.J., Schad C.A., Kwon A.Y., and Skoner D.P. Addressing steroid phobia: improving the risk-benefit ratio with new agents. Allergy Asthma Proc 29 (2008) 358-364
3. Derendorf H., and Hochhaus G. What is the best marker for inhaled corticosteroid safety?. Allergy Asthma Proc 26 (2005) 89-93
4. Lipworth B.J. Systemic adverse effects of inhaled corticosteroid therapy. Arch Intern Med 159 (1999) 941-955
5. Langlois A., Ferland C., Tremblay G.M., and Laviolette M. Montelukast regulates eosinophil protease activity through a leukotriene-independent mechanism. J Allergy Clin Immunol 118 (2006) 113-119
6. Muz M.H., Deveci F., Bulut Y., Ilhan N., Yekeler H., and Turgut T. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model. Exp Mol Med 38 (2006) 109-118
7. Profita M., Sala A., Bonanno A., Siena L., Ferraro M., Di Giorgi R., et al. Cysteinyl leukotriene-1 receptor activation in a human bronchial epithelial cell line leads to signal transducer and activator of transcription 1-mediated eosinophil adhesion. J Pharmacol Exp Ther 325 (2008) 1024-1030
8. Joos S., Miksch A., Szecsenyi J., Wieseler B., Grouven U., Kaiser T., et al. Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review. Thorax 63 (2008) 453-462
9. Riccioni G., Bucciarelli T., Mancini B., Di Ilio C., and D'Orazio N. Antileukotriene drugs: clinical application, effectiveness and safety. Curr Med Chem 14 (2007) 1966-1977
10. Ramsay C.F., Sullivan P., Gizycki M., Wang D., Swern A.S., and Barnes N.C. Montelukast and bronchial inflammation in asthma: A randomised, double-blind placebo-controlled trial. Respir Med 103 (2009) 995-1003
11. Minciullo P.L., Saija A., Bonanno D., Ferlazzo E., and Gangemi S. Montelukast-induced generalized urticaria. Ann Pharmacother 38 (2004) 999-1001
12. Incecik F., Onlen Y., Sangun O., and Akoglu S. Probable montelukast-induced hepatotoxicity in a pediatric patient: case report. Ann Saudi Med 27 (2007) 462-463
13. Sass D.A., Chopra K.B., and Wu T. A case of montelukast-induced hepatotoxicity. Am J Gastroenterol 98 (2003) 704-705
14. Tohda Y., Muraki M., Kubo H., Itoh M., Haraguchi R., Nakajima S., et al. Role of chemical mediators in airway hyperresponsiveness in an asthmatic model. Respiration 68 (2001) 73-77
15. Tohda Y., Ohkawa K., Kubo H., Muraki M., Fukuoka M., and Nakajima S. Role of GABA receptors in the bronchial response: studies in sensitized guinea-pigs. Clin Exp Allergy 28 (1998) 772-777
16. Tohda Y., Haraguchi R., Itoh M., Ohkawa K., Kubo H., Fukuoka M., et al. Role of muscarinic acetylcholine receptors in a guinea pig model of asthma. Int Immunopharmacol 2 (2002) 1521-1527
17. Muraki M., Iwanaga T., Haraguchi R., Kubo H., and Tohda Y. Continued inhalation of lidocaine suppresses antigen-induced airway hyperreactivity and airway inflammation in ovalbumin-sensitized guinea-pigs. Int Immunopharmacol 8 (2008) 725-731
18. Muraki M., Tohda Y., Sugihara R., Nagasaka Y., and Nakajima S. The effect of TYB-2285 on dual phase bronchoconstriction and airway hypersensitivity in guinea-pigs actively sensitized with ovalbumin. J Pharm Pharmacol 46 (1994) 883-886
19. Currie G.P., and McLaughlin K. The expanding role of leukotriene receptor antagonists in chronic asthma. Ann Allergy Asthma Immunol 97 (2006) 731-741
20. Bjermer L., Bisgaard H., Bousquet J., Fabbri L.M., Greening A.P., Haahtela T., et al. Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial. BMJ 327 (2003) 891-895
21. Kelly M.M., Chakir J., Vethanayagam D., Boulet L.P., Laviolette M., Gauldie J., et al. Montelukast treatment attenuates the increase in myofibroblasts following low-dose allergen challenge. Chest 130 (2006) 741-753
22. Henderson Jr. W.R., Tang L.O., Chu S.J., Tsao S.M., Chiang G.K., Jones F., et al. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am J Respir Crit Care Med 165 (2002) 108-116
23. Holgate S.T., Peters-Golden M., Panettieri R.A., and Henderson Jr. W.R. Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling. J Allergy Clin Immunol 111 1 Suppl (2003) S18-S36
24. McKinley L., Kim J., Bolgos G.L., Siddiqui J., and Remick D.G. Allergens induce enhanced bronchoconstriction and leukotriene production in C5 deficient mice. Respir Res 17 7 (2006) 129
25. Bossé Y., Thompson C., McMahon S., Dubois C.M., Stankova J., and Rola-Pleszczynski M. Leukotriene D4-induced, epithelial cell-derived transforming growth factor beta1 in human bronchial smooth muscle cell proliferation. Clin Exp Allergy 38 (2008) 113-121
26. Gyllfors P., Dahlén S.E., Kumlin M., Larsson K., and Dahlén B. Bronchial responsiveness to leukotriene D4 is resistant to inhaled fluticasone propionate. J Allergy Clin Immunol 118 (2006) 78-83
27. Dockhorn R.J., Baumgartner R.A., Leff J.A., Noonan M., Vandormael K., Stricker W., et al. Comparison of the effects of intravenous and oral montelukast on airway function: a double blind, placebo controlled, three period, crossover study in asthmatic patients. Thorax 55 (2000) 260-265
28. Stoloff S.W., Stempel D.A., Meyer J., Stanford R.H., and Carranza Rosenzweig J.R. Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies. J Allergy Clin Immunol 113 (2004) 245-251